FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
FGF-1 is being used for the treatment of patients with diabetic or venous stasis ulcers.
Procedure includes topical administration of FGF-1 or placebo and evaluation of safety,
pharmacokinetics, and wound improvement.